LZ
Lonza Group AG
LZAGY · OTC
$67.07 +1.16% (+$0.77)
1M -9.46%
Market Cap CHF 39.2B
P/E Ratio 41.28x
Div. Yield 0.85%
ROE 10.78%
Bulios Fair Price
$58.93
12.1% downside
Trenutna cena
$67.07
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica LZAGY trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Strong
7/9Valuation
23 /100
Expensive P/E 41.28x
P/B 4.29x
EV/EBITDA 32.55x
Growth
14 /100
Declining EPS growth 6.09%
Book val. growth 4.83%
Rev. growth 1.62%
Profitability
56 /100
Moderate Gross margin 35.35%
FCF margin 2.98%
Net margin 14.53%
Quality
41 /100
Average ROIC 6.87%
Asset turnover 0.34x
ROE 10.78%
Debt
73 /100
Low Debt/Equity 0.46x
Net debt/EBITDA 2.65x
Current ratio 2.24x
Stability
82 /100
Stable Beta 0.84x
Profitable years 6
Rev. volatility 5.44%
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o LZAGY
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Wolfgang Wienand
Employees
16,866
Headquarters
Basel